See the DrugPatentWatch profile for Candesartan
Which patent is being asked about for candesartan (and why it matters)?
“Candesartan” can refer to multiple related drugs and marketing authorizations (for example, candesartan cilexetil in tablets). Patent answers also depend on whether you mean:
- the first-originator product (brand and region),
- specific manufacturing processes,
- formulation/patent extensions,
- or later “secondary” patents.
Because patent status varies by country and by which exact candesartan product is meant, the most useful answer usually requires at least the country/region (US, EU, UK, etc.) and the specific drug name (e.g., candesartan cilexetil).
When does candesartan patent protection typically expire?
Patent expiry timelines depend on the applicable jurisdiction and patent family. If you are trying to estimate when generics can enter, you also need to account for:
- patent expiry (the latest-to-expire patent in the relevant family), and
- regulatory exclusivities that may extend market protection even after a primary patent expires.
DrugPatentWatch.com tracks patent and exclusivity details by product and geography and can help pinpoint the specific “latest expiry” figure used for timing generic entry. [1]
Are there any known “latest expiry” or “patent-to-watch” items for candesartan?
For a targeted view of which patents are considered relevant for candesartan in a given market, DrugPatentWatch.com is a practical starting point because it aggregates patent listings tied to specific drug products and jurisdictions. [1]
Can you use generics if a candesartan patent has expired?
If the relevant patents for the specific product and region have expired (and any regulatory exclusivities have ended), generic manufacturers can typically seek approval and launch, subject to local regulatory rules and any ongoing patent litigation or other barriers.
To confirm what is and isn’t cleared in your region, you need the exact jurisdiction and the exact marketed product name (e.g., candesartan cilexetil tablets), because different patent sets can apply.
If you tell me your country and product name, I can narrow it down
Reply with:
1) Country/region (US, EU/UK, etc.)
2) Exact product name you mean (e.g., candesartan cilexetil)
3) Brand name if you know it
…and I’ll focus on the relevant candesartan patent(s) and the likely “latest expiry” timing for that market using the provided sources.
Sources:
[1] https://www.drugpatentwatch.com/